Arachidonic acid cytochrome P450 4F2 in hypertension: What can we learn from a transgenic mouse model?

8Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The cytochrome P450-derived 20-hydroxyeicosatetraenoic acid (20-HETE) has known function that plays opposite roles in blood pressure: prohypertensive and antihypertensive. Liu et al. report that the CYP4F2 transgene, driven under an exogenous promoter, increases 20-HETE production and is associated with increased blood pressure in vivo. This study provides evidence for the first time that overexpression of P450 4F2 enzyme results in higher production of 20-HETE, which promotes hypertension. The significance of this transgenic mouse model is further discussed. © 2009 International Society of Nephrology.

Cite

CITATION STYLE

APA

Cai, Y. (2009). Arachidonic acid cytochrome P450 4F2 in hypertension: What can we learn from a transgenic mouse model? Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2009.82

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free